Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Tsuchiya

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Journal of Gastroenterology|July 18, 2013
Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis CYasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, et al.
Journal of Medical Virology|September 5, 2020
Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis CMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|May 31, 2021
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patientsShun Kaneko, Masayuki Kurosaki, Kento Inada, et al.
Liver Cancer|October 27, 2016
Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib TreatmentHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral responseYasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitisKento Inada, Shun Kaneko, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 8, 2015
Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapyJun Itakura, Masayuki Kurosaki, Hitomi Takada, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 11, 2025
Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter StudyYasuyuki Komiyama, Nobuharu Tamaki, Keiji Tsuji, et al.
International Journal of Molecular Sciences|May 28, 2020
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-fetoprotein as a Long-Term Hepatocellular Carcinoma PredictorLeona Osawa, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Alimentary Pharmacology & Therapeutics|December 20, 2021
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortalityMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Journal of Gastroenterology|July 18, 2013
Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis CYasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, et al.
Journal of Medical Virology|September 5, 2020
Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis CMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|May 31, 2021
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patientsShun Kaneko, Masayuki Kurosaki, Kento Inada, et al.
Liver Cancer|October 27, 2016
Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib TreatmentHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral responseYasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitisKento Inada, Shun Kaneko, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 8, 2015
Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapyJun Itakura, Masayuki Kurosaki, Hitomi Takada, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 11, 2025
Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter StudyYasuyuki Komiyama, Nobuharu Tamaki, Keiji Tsuji, et al.
International Journal of Molecular Sciences|May 28, 2020
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-fetoprotein as a Long-Term Hepatocellular Carcinoma PredictorLeona Osawa, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Alimentary Pharmacology & Therapeutics|December 20, 2021
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortalityMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 15